FDA-Approved Medications for Opioid Use Disorder Now Available for Title IV-E Prevention Services

FDA-Approved Medications for Opioid Use Disorder Now Available for Title IV-E Prevention Services

The U.S. Department of Health and Human Services through its Administration for Children and Families (ACF) today announced that three U.S. Food and Drug Administration-approved Medications for Opioid Use Disorder (MOUD) have been added as prevention services eligible for funding under Title IV-E, which supports children and families involved with the child welfare system.

Please see a letter from the Assistant Secretary regarding these changes, along with the related language jurisdictions may use to amend their Title IV-E Prevention Plans.

• Letter from ACF Assistant Secretary Alex J. Adams
• Title IV-E Prevention MOUD Sample Language

Received this message from a colleague? Get News From CB sent to your inbox.

News From CB is sent by Child Welfare Information Gateway on behalf of the Children’s Bureau to support child welfare professionals in strengthening the well-being of children and families.

Sign up to receive other important news digests from Information Gateway and the Children’s Bureau.